SPECIAL NOTICE
A -- RRPV Solicitation Summary: NextGen Vaccinations: Phase 2B Clinical Trial Execution
- Notice Date
- 12/1/2023 9:05:49 AM
- Notice Type
- Special Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
- ZIP Code
- 20515
- Solicitation Number
- RPP-24-04-NGVx
- Response Due
- 1/10/2024 12:00:00 PM
- Archive Date
- 01/25/2024
- Point of Contact
- Rebecca Harmon
- E-Mail Address
-
rebecca.harmon@ati.org
(rebecca.harmon@ati.org)
- Description
- This solicitation summary is to notify all potential offerors of a Request for Project Proposals�(RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority (BARDA), titled, �NextGen Vaccinations: Phase 2B Clinical Trial Execution�.� The full RPP as well as information on joining the consortium can be accessed through the RRPV website at www.rrpv.org.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/0c0d8cab04bd4ac8a0295772fdda0e93/view)
- Record
- SN06900134-F 20231203/231201230047 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |